Producing cGMP intermediates like sofosbuvir precursors (purity >99.5%), we accelerate drug manufacturing for WHO-approved APIs. Our closed-loop synthesis system reduces solvent waste by 90%, as validated in a 2022 partnership with a Swiss pharma leader. [Include chromatography analysis reports and CTA for custom synthesis inquiries.]
Pharmaceutical Intermediates: Precision Chemistry for Global Health
- yundic
